Concourse Financial Group Securities, Inc. Editas Medicine, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 75 shares of EDIT stock, worth $93. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Previous 75 -0.0%
Holding current value
$93
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023
SELL
$6.92 - $9.31 $6,677 - $8,984
-965 Reduced 92.79%
75 $0
Q2 2023

Aug 10, 2023
BUY
$6.36 - $11.47 $5,088 - $9,176
800 Added 333.33%
1,040 $8,000
Q1 2023

May 15, 2023
SELL
$7.03 - $11.53 $2,812 - $4,612
-400 Reduced 62.5%
240 $1,000
Q2 2022

Aug 09, 2022
BUY
$9.99 - $21.35 $1,998 - $4,270
200 Added 45.45%
640 $8,000
Q1 2022

May 09, 2022
SELL
$14.08 - $27.63 $4,899 - $9,615
-348 Reduced 44.16%
440 $8,000
Q4 2021

Feb 07, 2022
SELL
$26.55 - $40.57 $16,912 - $25,843
-637 Reduced 44.7%
788 $21,000
Q3 2021

Nov 09, 2021
SELL
$39.27 - $72.94 $4,201 - $7,804
-107 Reduced 6.98%
1,425 $59,000
Q2 2021

Aug 13, 2021
SELL
$31.29 - $56.64 $34,669 - $62,757
-1,108 Reduced 41.97%
1,532 $86,000
Q1 2021

May 13, 2021
BUY
$39.71 - $90.58 $74,694 - $170,380
1,881 Added 247.83%
2,640 $111,000
Q4 2020

Feb 02, 2021
BUY
$27.07 - $84.35 $13,101 - $40,825
484 Added 176.0%
759 $53,000
Q4 2019

Feb 14, 2020
BUY
$19.49 - $32.63 $1,461 - $2,447
75 Added 37.5%
275 $8,000
Q4 2018

Feb 14, 2019
BUY
$18.19 - $31.79 $1,819 - $3,179
100 Added 100.0%
200 $4,000
Q3 2018

Nov 13, 2018
BUY
$27.65 - $38.39 $2,765 - $3,839
100 New
100 $3,000

Others Institutions Holding EDIT

# of Institutions
240
Shares Held
56.5M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $85.9M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email